Market Closed -
Other stock markets
|
After market 03:27:02 pm | |||
41.6 EUR | +4.13% | 42.45 | +2.04% |
Apr. 25 | Formycon AG Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 18 | Formycon, Fresenius Kabi Sign Settlement Deal with Johnson & Johnson for Ustekinumab Biosimilar | MT |
Sales 2024 * | 60.85M 65.22M | Sales 2025 * | 75.02M 80.42M | Capitalization | 706M 756M |
---|---|---|---|---|---|
Net income 2024 * | -14M -15.01M | Net income 2025 * | 13M 13.93M | EV / Sales 2024 * | 10.4 x |
Net cash position 2024 * | 70.67M 75.75M | Net cash position 2025 * | 74.87M 80.25M | EV / Sales 2025 * | 8.41 x |
P/E ratio 2024 * |
-55.5
x | P/E ratio 2025 * |
-3,995
x | Employees | 224 |
Yield 2024 * |
-
| Yield 2025 * |
0.91% | Free-Float | 42.17% |
1 day | +6.26% | ||
1 week | +8.90% | ||
Current month | -10.25% | ||
1 month | -7.86% | ||
3 months | -17.95% | ||
6 months | -23.11% | ||
Current year | -26.24% |
Managers | Title | Age | Since |
---|---|---|---|
Stefan Glombitza
CEO | Chief Executive Officer | - | 16-09-30 |
Enno Spillner
DFI | Director of Finance/CFO | 55 | 23-03-31 |
Andreas Seidl
CTO | Chief Tech/Sci/R&D Officer | - | 22-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Olaf Stiller
FOU | Founder | 47 | 06-12-31 |
Peter Wendeln
BRD | Director/Board Member | 59 | - |
Klaus Röhrig
BRD | Director/Board Member | 47 | 20-12-09 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.47% | 17 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-29 | 41.6 | +4.13% | 11 579 |
24-04-26 | 39.95 | +0.63% | 4,802 |
24-04-25 | 39.7 | +1.53% | 5,054 |
24-04-24 | 39.1 | 0.00% | 6,386 |
24-04-23 | 39.1 | +2.36% | 16,546 |
Delayed Quote Xetra, April 29, 2024 at 11:36 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-26.24% | 753M | |
+1.64% | 42.75B | |
+47.70% | 41.61B | |
+12.15% | 41.34B | |
-8.83% | 26.59B | |
+6.62% | 25.49B | |
-23.36% | 18.12B | |
+30.00% | 12.24B | |
-2.42% | 11.76B | |
+8.06% | 11B |
- Stock Market
- Equities
- FYB Stock